<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Maggiore JC</submitter><funding>NIBIB NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NIH HHS</funding><pubmed_abstract>Vascularization plays a critical role in organ maturation and cell type development. Drug discovery, organ mimicry, and ultimately transplantation in a clinical setting thereby hinges on achieving robust vascularization of &lt;i>in vitro&lt;/i> engineered organs. Here, focusing on human kidney organoids, we overcome this hurdle by combining an inducible &lt;i>ETS translocation variant 2&lt;/i> (&lt;i>ETV2&lt;/i>) human induced pluripotent stem cell (iPSC) line, which directs endothelial fate, with a non-transgenic iPSC line in suspension organoid culture. The resulting human kidney organoids show extensive vascularization by endothelial cells with an identity most closely related to endogenous kidney endothelia. Vascularized organoids also show increased maturation of nephron structures including more matur</pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2023.05.30.542848</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10274893</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Genetically engineering endothelial niche in human kidney organoids enables multilineage maturation, vascularization and de novo cell types.</pubmed_title><pmcid>PMC10274893</pmcid><funding_grant_id>R01 HL141805</funding_grant_id><funding_grant_id>R56 DK125960</funding_grant_id><funding_grant_id>R01 DK127634</funding_grant_id><funding_grant_id>P30 DK079307</funding_grant_id><funding_grant_id>RC2 DK125960</funding_grant_id><funding_grant_id>UC2 DK126122</funding_grant_id><funding_grant_id>R01 EB024562</funding_grant_id><funding_grant_id>R01 EB028532</funding_grant_id><funding_grant_id>S10 OD019973</funding_grant_id><funding_grant_id>T32 EB001026</funding_grant_id><pubmed_authors>Maggiore JC</pubmed_authors><pubmed_authors>Carroll TJ</pubmed_authors><pubmed_authors>LeGraw R</pubmed_authors><pubmed_authors>Little M</pubmed_authors><pubmed_authors>Wu H</pubmed_authors><pubmed_authors>Sims-Lucas S</pubmed_authors><pubmed_authors>Velazquez J</pubmed_authors><pubmed_authors>Pfister K</pubmed_authors><pubmed_authors>Watson A</pubmed_authors><pubmed_authors>Hill A</pubmed_authors><pubmed_authors>Przepiorski A</pubmed_authors><pubmed_authors>Silva-Barbosa A</pubmed_authors><pubmed_authors>Hislop J</pubmed_authors><pubmed_authors>Stolz DB</pubmed_authors><pubmed_authors>Streeter E</pubmed_authors><pubmed_authors>Ebrahimkhani MR</pubmed_authors><pubmed_authors>Chaney C</pubmed_authors><pubmed_authors>Franks J</pubmed_authors><pubmed_authors>Humphreys BD</pubmed_authors><pubmed_authors>Watkins SC</pubmed_authors><pubmed_authors>Howden SE</pubmed_authors><pubmed_authors>Hukriede NA</pubmed_authors><pubmed_authors>Kiani S</pubmed_authors><pubmed_authors>Cleaver O</pubmed_authors><pubmed_authors>Davidson AJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genetically engineering endothelial niche in human kidney organoids enables multilineage maturation, vascularization and de novo cell types.</name><description>Vascularization plays a critical role in organ maturation and cell type development. Drug discovery, organ mimicry, and ultimately transplantation in a clinical setting thereby hinges on achieving robust vascularization of &lt;i>in vitro&lt;/i> engineered organs. Here, focusing on human kidney organoids, we overcome this hurdle by combining an inducible &lt;i>ETS translocation variant 2&lt;/i> (&lt;i>ETV2&lt;/i>) human induced pluripotent stem cell (iPSC) line, which directs endothelial fate, with a non-transgenic iPSC line in suspension organoid culture. The resulting human kidney organoids show extensive vascularization by endothelial cells with an identity most closely related to endogenous kidney endothelia. Vascularized organoids also show increased maturation of nephron structures including more matur</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2026-06-22T03:22:21.634Z</modification><creation>2026-06-22T03:09:06.323Z</creation></dates><accession>S-EPMC10274893</accession><cross_references><pubmed>37333155</pubmed><doi>10.1101/2023.05.30.542848</doi></cross_references></HashMap>